Health Condition 1: J00-J99- Diseases of the respiratory system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Consecutive patients undergoing flexible bronchoscopy during study period will be considered eligible for inclusion if they are 1.Aged above 18 years 2.Hemodynamically stable(defined systolic B.P >100mmHg,
Exclusion criteria
Exclusion criteria: 1. Failure to provide informed consent 2. Documented history of lignocaine toxicity 3. Pregnancy 4. Patients undergoing TBNA and other interventions 5. Wherein bronchoscopy was performed through endotracheal or tracheostomy tube
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the cough scores during the procedure between two study groups that is 1% lignocaine and 2% lignocaine by using VAS score(0-100mm)Timepoint: 1.Immediately after procedure- Cough score as assessed by bronchoscopist,respiratory therapist and staff nurse assisting the procedure 2.Two hours after procedure-cough score as assessed by patient | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine overall complication rate in number while undergoing bronchoscopy procedures in 1% vs 2% lignocaineTimepoint: immediately after the procedure;To determine overall feel of scopy as assessed by patient based on FACES pain scale scoreTimepoint: within 2 hours of procedure;To determine overall feel of scopy for the operator based on VAS score(0-100mm scale)Timepoint: immediately after the procedure;To determine total dose of lignocaine (in mg) used while performing procedure for 1% vs 2% concentrationsTimepoint: immediately after the procedure | — |
Countries
India
Contacts
CMC,Vellore